Call (844) 879-2237

Request additional information regarding Cerafix®

A Material Development Company

A bioscience company commercializing a portfolio of fully synthetic electrospun scaffolds for regenerative medical applications

Feature image

The FDA cleared Acera’s first product in March 2016 and its second product in April 2017, both via 510(k). Acera is currently raising Series A financing, as well as seeking strategic partners for product development and commercialization.

Feature image
Premium WordPress Themes with Single Click

The Theme had a simple layout which attracts the Client to the Website. Also, the professional and Clean design .

Feature image
Acera Meshes
Biologic Properties

The Theme had a simple layout which attracts the Client to the Website. Also, the professional and Clean design .

Feature image
Acera Performance
Investment Opportunities

The Theme had a simple layout which attracts the Client to the Website. Also, the professional and Clean design .

Acera News

Post Image

Acera’s SAWC 2017 Poster

Read More

Acera Surgical Publishes Manuscript Highlighting the Mechanism of Action of Nanofabricated Restrata™ Wound Matrix

St. Louis, MO— October 5th, 2017— Acera Surgical Inc., a bioscience company dedicated to the commercialization of fully synthetic electrospun scaffolds for regenerative medical applications, announced today the publication of scientific manuscript describing the mechanism of action of the Restrata™ […]

Read More